BRK-B vs FLC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FLC presents as a classic value trap with a stable Piotroski F-Score of 5/9 and a significant discount to its Graham Number ($25.61). While the stock trades attractively below book value (P/B 0.90) and offers a strong 7.15% dividend yield, it is plagued by negative earnings growth (-10.90%) and a completely bearish technical trend (0/100). The high profit margins provide a safety buffer, but the lack of growth and poor insider sentiment suggest limited upside potential in the near term.
Compare Another Pair
Related Comparisons
BRK-B vs FLC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Flaherty & Crumrine Total Return Fund Inc. (FLC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.